We are live on ! Find out more
CIM

CIM Investment Management Portfolio holdings

AUM $375M
1-Year Est. Return 32.03%
This Fund
S&P 500
This Quarter Est. Return
-5.89%
1 Year Est. Return
+32.03%
3 Year Est. Return
+88.62%
5 Year Est. Return
+95.83%
10 Year Est. Return
+334.77%
AUM
$296M
AUM Growth
-$38M
Cap. Flow
-$19.6M
Cap. Flow %
-6.63%
Top 10 Hldgs %
47.05%
Holding
319
New
20
Increased
47
Reduced
179
Closed
70

Sector Composition

Rank Sector Weight
1 Technology 17.25%
2 Consumer Discretionary 9.57%
3 Financials 8.04%
4 Healthcare 7.77%
5 Industrials 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRLB icon
226
Protolabs
PRLB
$2.16B
$213K 0.07%
4,028
-469
-10% -$24.7K
BCO icon
227
Brink's
BCO
$4.69B
$209K 0.07%
3,074
-3,800
-55% -$260K
FCF icon
228
First Commonwealth Financial
FCF
$2.18B
$209K 0.07%
13,761
-1,600
-10% -$26K
ZWS icon
229
Zurn Elkay Water Solutions
ZWS
$8.6B
$209K 0.07%
5,895
-686
-10% -$22.8K
NGVT icon
230
Ingevity
NGVT
$2.67B
$206K 0.07%
3,214
-373
-10% -$25K
FFIN icon
231
First Financial Bankshares
FFIN
$4.99B
$204K 0.07%
4,631
-539
-10% -$25.8K
HALO icon
232
Halozyme
HALO
$11.6B
$204K 0.07%
5,108
-604
-11% -$21.5K
BXMT icon
233
Blackstone Mortgage Trust
BXMT
$2.47B
$203K 0.07%
6,387
-741
-10% -$23.3K
HUBG icon
234
HUB Group
HUBG
$2.32B
$203K 0.07%
5,248
-612
-10% -$24.5K
KYNB
235
Kyntra Bio
KYNB
$28.6M
$202K 0.07%
671
-78
-10% -$27.2K
SSYS icon
236
Stratasys
SSYS
$782M
$202K 0.07%
7,961
-925
-10% -$22.3K
ALXO icon
237
ALX Oncology
ALXO
$267M
$181K 0.06%
+10,706
New +$183K
FOLD
238
DELISTED
Amicus Therapeutics
FOLD
$181K 0.06%
19,082
-2,222
-10% -$20.8K
ATOM icon
239
Atomera
ATOM
$217M
$180K 0.06%
13,813
-1,609
-10% -$24.1K
QUOT
240
DELISTED
Quotient Technology Inc
QUOT
$162K 0.05%
25,370
-2,944
-10% -$19.7K
FIRY
241
Firy Inc
FIRY
$160M
$158K 0.05%
2,634
+742
+39% +$60.5K
TGTX icon
242
TG Therapeutics
TGTX
$7.64B
$143K 0.05%
+14,986
New +$173K
PACB icon
243
Pacific Biosciences
PACB
$354M
$142K 0.05%
+15,582
New +$179K
VTVT icon
244
vTv Therapeutics
VTVT
$130M
$115K 0.04%
3,973
-461
-10% -$13.8K
WKHS icon
245
Workhorse Group
WKHS
$34.1M
$114K 0.04%
8
GRWG icon
246
GrowGeneration
GRWG
$89.5M
$112K 0.04%
12,161
-1,412
-10% -$12.7K
OPK icon
247
Opko Health
OPK
$1.04B
$112K 0.04%
32,668
-3,818
-10% -$13.5K
BNGO icon
248
Bionano Genomics
BNGO
$13.7M
$69K 0.02%
44
-6
-12% -$8.1K
DHC
249
Diversified Healthcare Trust
DHC
$1.98B
$42K 0.01%
13,229
-1,536
-10% -$4.69K
ABBV icon
250
AbbVie
ABBV
$442B
-5,099
Closed -$690K

Similar funds

CIM Investment Management's Q1 2022 Portfolio in Review

As of Q1 2022, CIM Investment Management held 319 positions worth $296M, down 11% from $334M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

CIM Investment Management withdrew a net $19.6M in Q1 2022, closing 70 positions and reducing 179 holdings. Its most notable exit was Live Nation Entertainment, an estimated $1.58M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, CIM Investment Management opened a new position in Albemarle worth $980K.

  • CIM Investment Management's largest Q1 2022 buy was Albemarle: 4,430 shares worth $980K.
  • CIM Investment Management added most to iShares Core S&P Small-Cap ETF in Q1 2022, an estimated $3.65M increase.
  • CIM Investment Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $7.72M.
  • CIM Investment Management fully exited Live Nation Entertainment in Q1 2022, selling an estimated $1.58M.
  • CIM Investment Management's ten largest holdings make up 47% of its $296M portfolio in Q1 2022.
  • CIM Investment Management opened 20 new positions and closed 70 in Q1 2022.
  • CIM Investment Management's portfolio value fell 11% quarter-over-quarter to $296M.

Based on CIM Investment Management's 13F filing for Q1 2022, filed 17 May 2022.